Biggest News Aggregation in the World
📰 Imaging Science News

Page 6 - Imaging Science News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Imaging Science. Real-time updates on events, politics, business and more.

Study opens up a new approach to incorporating MRI into multisite pancreatic clinical trials

Researchers with the Vanderbilt Diabetes Research and Training Center (DRTC) at Vanderbilt University Medical Center led a multisite study which has demonstrated that, when controlled and standardized, quantitative magnetic resonance imaging (MRI) of the pancreas is highly reproducible when using different MRI hardware and software at different geographic locations.
United States Vanderbilt University Daniel Moore John Virostko Emily Henderson University Of Texas At Austin

Senior Staff Imaging Scientist - Nikon Research Corporation of America, Belmont, CA, United States

Senior Staff Imaging Scientist Employer Description Nikon Research Corporation of America (NRCA), located in the San Francisco Bay Area in Belmont, CA, is a 70-person R&D subsidiary of Nikon Corporation in Japan.  We perform industrial research for all of the Nikon businesses, including semiconductor lithography, professional-grade cameras, and optical instruments and microscopes. Our work environment includes not only the informality and flexibility of a small company but also the stability a...
United States Nikon Research Corporation Of America Nikon Corporation Senior Staff Imaging Research Corporation San Francisco Bay Area
Source: optics.org

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Defining File Format Obsolescence: A Risky Journey

1 July 2008 - 12:00 An article by David Pearson and Colin Webb. This paper talks about the nature of file format obsolescence and a series of prototype questions designed by the National Library as a benchmark to help assess file format obsolescence. The article was published in the International Journal of Digital Curation, Vol 3, No 1 (2008). Introduction We know that in our information-obsessed world, change is everything. And yet some information is required to live beyond the moment; some ...
United Kingdom United States Australian Capital Territory The Netherlands Jane Hunter Matthew Walker
Source: nla.gov.au

Scenic Labs introduces the LX1: Affordable and accurate bias lighting for the home

Scenic Labs introduces the LX1: Affordable and accurate bias lighting for the home Share Article LX1, the newest addition to Scenic Labs’ acclaimed MediaLight Bias Lighting lineup, offers breakthrough performance and unprecedented quality in a low-cost package, enhancing any home entertainment displays image and reduces eye strain. LX1 Bias Lighting starts at only $15. The simulated D65 / 6500K ColorGrade chip provides a calibrated white reference that enhances any displays image and reduces ...
Jason Rosenfeld Imaging Science Foundation Scenic Lab Medialight Bias Lighting System Imaging Science Scenic Labs
Source: prweb.com

RIT researchers using drones and artificial intelligence to help assess crop growth

 E-Mail Researchers at Rochester Institute of Technology are exploring ways to use drones and artificial intelligence to help farmers and other users assess how well fields of crops are growing. The National Science Foundation awarded Guoyu Lu, an assistant professor in RITs Chester F. Carlson Center for Imaging Science, more than $583,000 to spearhead the project. The researchers are aiming to create a cost-effective and accurate 3D reconstruction sensing system that can be equipped on unmann...
Guoyu Lu Jan Van Aardt Chesterf Carlson Center College Of Science National Science Foundation Researchers At Rochester Institute Of Technology

AgeneBio Announces Completion of Patient Enrollment in Phase 2B Clinical Trial to Evaluate AGB101 to Treat Amnestic Mild Cognitive Impairment Due to Alzheimer's Disease

AgeneBio Announces Completion of Patient Enrollment in Phase 2B Clinical Trial to Evaluate AGB101 to Treat Amnestic Mild Cognitive Impairment Due to Alzheimers Disease - Topline results expected in November 2022 News provided by Share this article Share this article BALTIMORE, April 21, 2021 /PRNewswire/ -- AgeneBio announced today that it has completed enrollment in a Phase 2B clinical trial evaluating the efficacy of AGB101, a once-a-day investigational medication to treat amnestic Mild Cogn...
United States Sharon Rosenzweig Lipson Richard Mohs Johns Hopkins University National Institutes Of Health Clinical Development For Agenebio

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science